Pharmaceuticals, Biotechnology and Life Sciences
WATERTOWN, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and…
NEW HAVEN, Conn. and NEW YORK, Nov. 19, 2021 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE:…
Nicosia, Cyprus, Nov. 19, 2021 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) reports that PJSC Kraspharma at the end of…
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive…
Primary results from ONAWA (SOLTI-1802) trial of ONA-XR in early breast cancer to be presented in addition to updates from…
LEXINGTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing…
Sandusky, OH, Nov. 19, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized…
Houston, TX, Nov. 18, 2021 (GLOBE NEWSWIRE) — RadioMedix, a clinical-stage biotechnology company developing radiotheranostic drugs, announced that it has…
MISSISSAUGA, Ontario, Nov. 18, 2021 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…
–– 58 of the original 59 subjects continue in the open-label extension portion of the Phase 2 trial. –– Phase…